Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Abschlussarbeit Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin
2018
|
| Schlagworte: | |
| Online-Zugang: | kostenfrei |
| Beschreibung: | Im Titel ist "2" nach "D" tiefgestellt |
| Beschreibung: | 1 Online-Ressource (x, 152 Seiten) Illustrationen, Diagramme |
Internformat
MARC
| LEADER | 00000nmm a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV045415711 | ||
| 003 | DE-604 | ||
| 005 | 20190121 | ||
| 006 | a m||| 00||| | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190118s2018 |||| o||u| ||||||eng d | ||
| 024 | 7 | |a urn:nbn:de:kobv:188-refubium-23717-3 |2 urn | |
| 035 | |a (OCoLC)1083277087 | ||
| 035 | |a (DE-599)BVBBV045415711 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-188 | ||
| 084 | |a 618 |2 FUB | ||
| 084 | |a 615 |2 FUB | ||
| 100 | 1 | |a Tarland, Andrea Emilia |e Verfasser |0 (DE-588)1175689181 |4 aut | |
| 245 | 1 | 0 | |a Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |c vorgelegt von Andrea Emilia Tarland, Biologin |
| 246 | 1 | 3 | |a Effects of 2-bromoterguride, a dopamine D 2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| 264 | 1 | |a Berlin |c 2018 | |
| 300 | |a 1 Online-Ressource (x, 152 Seiten) |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Im Titel ist "2" nach "D" tiefgestellt | ||
| 502 | |b Dissertation |c Freie Universität Berlin |d 2018 | ||
| 650 | 7 | |a rats |2 cabt | |
| 650 | 7 | |a animal models |2 cabt | |
| 650 | 7 | |a dopamine |2 cabt | |
| 650 | 7 | |a receptors |2 cabt | |
| 650 | 7 | |a schizophrenia |2 cabt | |
| 650 | 7 | |a ELISA |2 cabt | |
| 655 | 7 | |0 (DE-588)4113937-9 |a Hochschulschrift |2 gnd-content | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |a Tarland, Andrea Emilia |t Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |w (DE-604)BV045415737 |
| 856 | 4 | 0 | |u https://refubium.fu-berlin.de/handle/fub188/23717 |x Resolving-System |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030801685 | ||
Datensatz im Suchindex
| _version_ | 1804179291060043776 |
|---|---|
| any_adam_object | |
| author | Tarland, Andrea Emilia |
| author_GND | (DE-588)1175689181 |
| author_facet | Tarland, Andrea Emilia |
| author_role | aut |
| author_sort | Tarland, Andrea Emilia |
| author_variant | a e t ae aet |
| building | Verbundindex |
| bvnumber | BV045415711 |
| collection | ebook |
| ctrlnum | (OCoLC)1083277087 (DE-599)BVBBV045415711 |
| format | Thesis Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01963nmm a2200445 c 4500</leader><controlfield tag="001">BV045415711</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190121 </controlfield><controlfield tag="006">a m||| 00||| </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190118s2018 |||| o||u| ||||||eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:kobv:188-refubium-23717-3</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1083277087</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045415711</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-188</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">618</subfield><subfield code="2">FUB</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">615</subfield><subfield code="2">FUB</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tarland, Andrea Emilia</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)1175689181</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia</subfield><subfield code="c">vorgelegt von Andrea Emilia Tarland, Biologin</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Effects of 2-bromoterguride, a dopamine D 2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (x, 152 Seiten)</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Im Titel ist "2" nach "D" tiefgestellt</subfield></datafield><datafield tag="502" ind1=" " ind2=" "><subfield code="b">Dissertation</subfield><subfield code="c">Freie Universität Berlin</subfield><subfield code="d">2018</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">rats</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">animal models</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">dopamine</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">receptors</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">schizophrenia</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ELISA</subfield><subfield code="2">cabt</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4113937-9</subfield><subfield code="a">Hochschulschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="a">Tarland, Andrea Emilia</subfield><subfield code="t">Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia</subfield><subfield code="w">(DE-604)BV045415737</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://refubium.fu-berlin.de/handle/fub188/23717</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030801685</subfield></datafield></record></collection> |
| genre | (DE-588)4113937-9 Hochschulschrift gnd-content |
| genre_facet | Hochschulschrift |
| id | DE-604.BV045415711 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:17:32Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030801685 |
| oclc_num | 1083277087 |
| open_access_boolean | 1 |
| owner | DE-188 |
| owner_facet | DE-188 |
| physical | 1 Online-Ressource (x, 152 Seiten) Illustrationen, Diagramme |
| psigel | ebook |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| record_format | marc |
| spelling | Tarland, Andrea Emilia Verfasser (DE-588)1175689181 aut Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia vorgelegt von Andrea Emilia Tarland, Biologin Effects of 2-bromoterguride, a dopamine D 2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia Berlin 2018 1 Online-Ressource (x, 152 Seiten) Illustrationen, Diagramme txt rdacontent c rdamedia cr rdacarrier Im Titel ist "2" nach "D" tiefgestellt Dissertation Freie Universität Berlin 2018 rats cabt animal models cabt dopamine cabt receptors cabt schizophrenia cabt ELISA cabt (DE-588)4113937-9 Hochschulschrift gnd-content Erscheint auch als Druck-Ausgabe Tarland, Andrea Emilia Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia (DE-604)BV045415737 https://refubium.fu-berlin.de/handle/fub188/23717 Resolving-System kostenfrei Volltext |
| spellingShingle | Tarland, Andrea Emilia Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia rats cabt animal models cabt dopamine cabt receptors cabt schizophrenia cabt ELISA cabt |
| subject_GND | (DE-588)4113937-9 |
| title | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| title_alt | Effects of 2-bromoterguride, a dopamine D 2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| title_auth | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| title_exact_search | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| title_full | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia vorgelegt von Andrea Emilia Tarland, Biologin |
| title_fullStr | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia vorgelegt von Andrea Emilia Tarland, Biologin |
| title_full_unstemmed | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia vorgelegt von Andrea Emilia Tarland, Biologin |
| title_short | Effects of 2-bromoterguride, a dopamine D2 receptor partial agonist, in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| title_sort | effects of 2 bromoterguride a dopamine d2 receptor partial agonist in animal models for negative symptoms and cognitive dysfunctions associated with schizophrenia |
| topic | rats cabt animal models cabt dopamine cabt receptors cabt schizophrenia cabt ELISA cabt |
| topic_facet | rats animal models dopamine receptors schizophrenia ELISA Hochschulschrift |
| url | https://refubium.fu-berlin.de/handle/fub188/23717 |
| work_keys_str_mv | AT tarlandandreaemilia effectsof2bromotergurideadopamined2receptorpartialagonistinanimalmodelsfornegativesymptomsandcognitivedysfunctionsassociatedwithschizophrenia |